Trichomoniasis, chlamydia, and gonorrhea are the three most prevalent, treatable STDs in the U.S. If left untreated, complications can include infertility, pelvic inflammatory disease, pregnancy complications, and increased risk of HIV acquisition.
1CDC recommends:
1- Annual CT/NG screening of all sexually active women under 25
- Screening of other at-risk individuals including MSM*
- Testing for chlamydia, gonorrhea, & trichomoniasis using NAATs^ (PCR)
- Timely testing and treatment
* DST – Doenças sexualmente transmissíveis
^ NAAT – Teste de amplificação de ácidos nucleicos
# PrEP – Profilaxia pré-exposição
(1) 2015 Diretriz europeia sobre o tratamento de infeções por Chlamydia trachomatis. Euro Surveill. 2015;20(48):30080.
(2) WHO Guidelines for the Treatment of Chlamydia Trachomatis. Consultado em junho 2020. https://apps.who.int/iris/bitstream/handle/10665/246165/9789241549714-eng.pdf?sequence=1
(3) WHO Guidelines for the Treatment of Neisseria gonorrhoeae. Consultado em junho 2020. https://apps.who.int/iris/bitstream/handle/10665/246114/9789241549691-eng.pdf?sequence=1
(4) 2012 Diretriz europeia sobre o diagnóstico e o tratamento de gonorreia em adultos. Int J STD AIDS. 2013 Feb;24(2):85-92.
(5)BHIVA/BASHH Guidelines on the Use of HIV Pre-Exposure Prophylaxis (PrEP) 2018. HIV Med. 2019 Mar;20 Suppl 2:s2-s80.